R G Vile

1.2k total citations
18 papers, 1.0k citations indexed

About

R G Vile is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, R G Vile has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in R G Vile's work include Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (4 papers). R G Vile is often cited by papers focused on Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (4 papers). R G Vile collaborates with scholars based in United Kingdom, United States and Denmark. R G Vile's co-authors include Kevin J. Harrington, J.S.W. Stewart, A. M. Peters, Paul S. Uster, Daphne M. Glass, S. Mohammadtaghi, J Whittaker, H. Chong, Stephen Todryk and Alan Melcher and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

R G Vile

18 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R G Vile United Kingdom 13 490 385 338 250 190 18 1.0k
Mingnan Chen United States 13 506 1.0× 531 1.4× 297 0.9× 226 0.9× 329 1.7× 26 1.2k
Gail Colbern United States 14 795 1.6× 707 1.8× 394 1.2× 310 1.2× 161 0.8× 20 1.5k
Folke Schriever Germany 19 315 0.6× 390 1.0× 364 1.1× 283 1.1× 579 3.0× 32 1.7k
Bing-Mae Chen Taiwan 16 440 0.9× 516 1.3× 252 0.7× 156 0.6× 233 1.2× 20 1.1k
Shabnum Patel United States 14 251 0.5× 455 1.2× 227 0.7× 273 1.1× 249 1.3× 27 1.1k
Huizi Sha China 17 245 0.5× 577 1.5× 309 0.9× 401 1.6× 277 1.5× 41 1.1k
Daniel Greenwald United States 9 381 0.8× 647 1.7× 341 1.0× 269 1.1× 179 0.9× 19 1.2k
Bing‐Mae Chen Taiwan 15 248 0.5× 510 1.3× 180 0.5× 182 0.7× 270 1.4× 25 1.1k
Lorena Simón‐Gracia Estonia 19 380 0.8× 630 1.6× 322 1.0× 172 0.7× 301 1.6× 36 1.2k
D Plocová Czechia 15 441 0.9× 348 0.9× 212 0.6× 129 0.5× 76 0.4× 19 797

Countries citing papers authored by R G Vile

Since Specialization
Citations

This map shows the geographic impact of R G Vile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R G Vile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R G Vile more than expected).

Fields of papers citing papers by R G Vile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R G Vile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R G Vile. The network helps show where R G Vile may publish in the future.

Co-authorship network of co-authors of R G Vile

This figure shows the co-authorship network connecting the top 25 collaborators of R G Vile. A scholar is included among the top collaborators of R G Vile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R G Vile. R G Vile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Harvey, Tracey J., Lynette P. Steele, Nicola Ingram, et al.. (2010). Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor. Gene Therapy. 17(8). 1000–1010. 14 indexed citations
2.
Seth, R., Andrew Hayes, Alan Melcher, et al.. (2010). Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?. Gene Therapy. 17(8). 949–960. 7 indexed citations
3.
Galivo, Feorillo, Rosa María Díaz, Phonphimon Wongthida, et al.. (2009). Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma. Gene Therapy. 17(2). 158–170. 63 indexed citations
4.
Vile, R G. (2006). Viral mediated cell fusion: Viral fusion – the making, or breaking, of a tumour?. Gene Therapy. 13(15). 1127–1130. 3 indexed citations
5.
Harrington, Kevin J., et al.. (2004). Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model. British Journal of Cancer. 91(2). 366–373. 11 indexed citations
6.
Harrington, Kevin J., et al.. (2001). Phase I–II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer. Annals of Oncology. 12(4). 493–496. 149 indexed citations
7.
Harrington, Kevin J., C. Lewanski, J Whittaker, et al.. (2001). Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck. European Journal of Cancer. 37(16). 2015–2022. 49 indexed citations
8.
Harrington, Kevin J., S. Mohammadtaghi, Paul S. Uster, et al.. (2001). Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.. PubMed. 7(2). 243–54. 461 indexed citations
9.
Harrington, Kevin J., Gail Rowlinson‐Busza, Konstantinos N. Syrigos, et al.. (2000). Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.. PubMed. 6(12). 4939–49. 70 indexed citations
10.
Vile, R G. (2000). Cancer gene therapy ? new approaches to tumour cell killing. The Journal of Gene Medicine. 2(2). 141–143. 15 indexed citations
11.
Melcher, Alan, et al.. (1999). Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity.. PubMed. 59(12). 2802–5. 42 indexed citations
12.
13.
14.
15.
Porter, Joanna C., et al.. (1998). Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer. British Journal of Cancer. 77(11). 1806–1811. 13 indexed citations
16.
Melcher, Alan, Ignacio Garcia‐Ribas, & R G Vile. (1997). Personal paper: Gene therapy for cancer—managing expectations. BMJ. 315(7122). 1604–1607. 4 indexed citations
17.
Vile, R G, Rosa María Díaz, Simon Castleden, & H. Chong. (1997). Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells. Biochemical Society Transactions. 25(2). 717–722. 21 indexed citations
18.
Miller, Nicholas & R G Vile. (1994). Gene transfer and antisense nucleic acid techniques. Parasitology Today. 10(3). 92–97. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingnan Chen Breakdown of academic impact, for papers by Gail Colbern Breakdown of academic impact, for papers by Folke Schriever Breakdown of academic impact, for papers by Bing-Mae Chen Breakdown of academic impact, for papers by Shabnum Patel Breakdown of academic impact, for papers by Huizi Sha Breakdown of academic impact, for papers by Daniel Greenwald Breakdown of academic impact, for papers by Bing‐Mae Chen Breakdown of academic impact, for papers by Lorena Simón‐Gracia Breakdown of academic impact, for papers by D Plocová
Rankless by CCL
2026